標(biāo)題: Titlebook: Combined Modality Therapy of Gastrointestinal Tract Cancer; Peter Schlag,Peter Hohenberger,Urs Metzger Conference proceedings 1988 Springe [打印本頁(yè)] 作者: Cataplexy 時(shí)間: 2025-3-21 17:58
書目名稱Combined Modality Therapy of Gastrointestinal Tract Cancer影響因子(影響力)
書目名稱Combined Modality Therapy of Gastrointestinal Tract Cancer影響因子(影響力)學(xué)科排名
書目名稱Combined Modality Therapy of Gastrointestinal Tract Cancer網(wǎng)絡(luò)公開(kāi)度
書目名稱Combined Modality Therapy of Gastrointestinal Tract Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Combined Modality Therapy of Gastrointestinal Tract Cancer被引頻次
書目名稱Combined Modality Therapy of Gastrointestinal Tract Cancer被引頻次學(xué)科排名
書目名稱Combined Modality Therapy of Gastrointestinal Tract Cancer年度引用
書目名稱Combined Modality Therapy of Gastrointestinal Tract Cancer年度引用學(xué)科排名
書目名稱Combined Modality Therapy of Gastrointestinal Tract Cancer讀者反饋
書目名稱Combined Modality Therapy of Gastrointestinal Tract Cancer讀者反饋學(xué)科排名
作者: 邪惡的你 時(shí)間: 2025-3-21 21:09
The Value of a Multidisciplinary Approach in the Management of Gastric Cancerby the Birmingham Cancer Registry. Between 1957 and 1976, 25255 patients with gastric cancer were registered and the 5-year survival is 5% (Fig. 1). An analysis of these patients by quinquennium and sex (Figs. 2 and 3) shows that there has been no change in the results of the management of this condition over this period.作者: 高深莫測(cè) 時(shí)間: 2025-3-22 01:22
Combined 5- Fluorouracil and Radiation Therapy Following Resection of Locally Advanced Gastric Carcid that a combined modality approach, including the delivery of radiation therapy to the tumor bed concomitant with chemotherapy as an adjuvant to surgery, may eradicate microscopic residual disease, reduce the local recurrence rate, and improve survival [3].作者: 偶像 時(shí)間: 2025-3-22 05:18
The True Role of External-Beam Irradiation in the Initial Treatment of Cancer of the Rectum in almost all these trials the irradiation does not alter the surgical procedure, and the majority of cured patients have a permanent colostomy. In the EORTC trial more than 85% of the patients underwent a mutilating operation.作者: COST 時(shí)間: 2025-3-22 12:31
0080-0015 ostoperative treatment have been in- vestigated with regard to their use in combination with surgi- cal intervention. It now is time to analyze and to define the state of our knowledge. For tumors of the gastrointestinal tract there are several encouraging therapeutic approaches, such as preop- erat作者: Glower 時(shí)間: 2025-3-22 16:30 作者: Glower 時(shí)間: 2025-3-22 20:59
Interim Analysis of a Double-Blind Phase-III Clinical Trial of Adjuvant Levamisole Versus Control inhad been obtained with immunotherapies (BCG, MER-BCG, Corynebacterium Parvum and Levamisole) in colorectal cancer were either ambiguous or based on uncontrolled trials when this trial was initiated by the EORTC in 1978.作者: 熟練 時(shí)間: 2025-3-22 22:48
Herbert Schumann,Ingeborg Schumannd that a combined modality approach, including the delivery of radiation therapy to the tumor bed concomitant with chemotherapy as an adjuvant to surgery, may eradicate microscopic residual disease, reduce the local recurrence rate, and improve survival [3].作者: FORGO 時(shí)間: 2025-3-23 04:21
https://doi.org/10.1007/978-1-4613-1477-6 in almost all these trials the irradiation does not alter the surgical procedure, and the majority of cured patients have a permanent colostomy. In the EORTC trial more than 85% of the patients underwent a mutilating operation.作者: VAN 時(shí)間: 2025-3-23 09:07 作者: 受傷 時(shí)間: 2025-3-23 09:53
Smoothing a Critical TransitionRadiotherapy is the usual treatment for inoperable esophageal carcinoma. Results published before 1976, when this trial was begun were very modest, except for those of Pearson [1], The 1-year survival rate varies from 15% to 30%, and 5-year survival rates were about 5% [2–7].作者: 絕食 時(shí)間: 2025-3-23 14:28
Smoothness Priors Analysis of Time SeriesIn an attempt to improve the conservative treatment of inoperable esophageal cancer we began 10 years ago to use the combined chemo-radiotherapy approach. Before conducting clinical trials we investigated the interaction of cytostatics and radiation in vitro on various cell lines.作者: antecedence 時(shí)間: 2025-3-23 19:35 作者: 赤字 時(shí)間: 2025-3-23 22:10 作者: Ergots 時(shí)間: 2025-3-24 05:49 作者: 過(guò)于光澤 時(shí)間: 2025-3-24 10:25
Controlled Clinical Trial for the Treatment of Patients with Inoperable Esophageal Carcinoma: A StudRadiotherapy is the usual treatment for inoperable esophageal carcinoma. Results published before 1976, when this trial was begun were very modest, except for those of Pearson [1], The 1-year survival rate varies from 15% to 30%, and 5-year survival rates were about 5% [2–7].作者: lethal 時(shí)間: 2025-3-24 11:32 作者: 你正派 時(shí)間: 2025-3-24 18:34
Phase-III Clinical Trial of Adjuvant FAM2 (5-FU, Adriamycin and Mitomycin C) vs Control in ResectablDespite a reported decrease in incidence, gastric carcinoma remains a major oncologic problem in Western Europe. Surgery is at present the only hope for cure. The 5-year survival after curative surgery is about 40% for stage 2 and 20% for stage 3.作者: 粗糙 時(shí)間: 2025-3-24 19:30 作者: Encoding 時(shí)間: 2025-3-25 00:20
Preoperative Radiotherapy and Radical Surgery as Combined Treatment in Rectal CancerIn 1976, the Gastrointestinal Group of the EORTC activated a clinical trial on rectal cancer with the aim of studying the efficacy of high-dose preoperative irradiation therapy (34.5 Gy) as an adjuvant before radical surgery. This was a multicentric prospective phase-III clinical trial.作者: rheumatism 時(shí)間: 2025-3-25 06:02
Recent Results in Cancer Researchhttp://image.papertrans.cn/c/image/230075.jpg作者: 改變立場(chǎng) 時(shí)間: 2025-3-25 11:23 作者: Frequency-Range 時(shí)間: 2025-3-25 14:04 作者: vocation 時(shí)間: 2025-3-25 19:44 作者: 半身雕像 時(shí)間: 2025-3-25 21:02 作者: lanugo 時(shí)間: 2025-3-26 00:39
Ricardo Maronna,Oscar Bustos,Victor Yohaial series showed a low rate of resectability and a high postoperative mortality. Results of radiation therapy alone were also disappointing in the long run, especially in patients who appeared to be excellent operative risks with small localized tumors. The rationale for a combined approach was that作者: Anemia 時(shí)間: 2025-3-26 04:29
https://doi.org/10.1007/978-981-15-4035-6or removal is possible only in some of the patients. There have been many efforts to search for ways of improving the treatment results in esophageal cancer [10]. These include surgical techniques [11, 14] as well as combined treatment modalities [3, 8, 15]. Nevertheless, the results obtained have b作者: BINGE 時(shí)間: 2025-3-26 12:27 作者: 哺乳動(dòng)物 時(shí)間: 2025-3-26 16:19
Herbert Schumann,Ingeborg Schumann gastric carcinoma, and the results depend on the extent and penetration of the tumor into the stomach wall and the involvement of the regional lymph nodes. Analysis of the patterns by failure revealed that in up to 90% of cases there is evidence of locore-gional recurrence [2]. It has been suggeste作者: 使成波狀 時(shí)間: 2025-3-26 19:53
https://doi.org/10.1007/978-3-662-06750-5but a recent necroscopy study from Norway has cast serious doubt on this, as the histologically proven incidence has been constant over a 15-year period [1], In the United Kingdom carcinoma of the stomach remains a common condition, accounting for over 10000 deaths a year. In the West Midlands, a mu作者: FAWN 時(shí)間: 2025-3-26 22:01 作者: agonist 時(shí)間: 2025-3-27 03:17 作者: 有權(quán) 時(shí)間: 2025-3-27 06:40
https://doi.org/10.1007/978-3-662-09147-0and the vast majority of patients die within 1 year of diagnosis. Overall survival at 3 years is practically zero [1]. The diagnosis of adenocarcinoma of the pancreas is most often made when the disease is already far advanced. It tends to spread rapidly intra-ab-dominally and can be called the sile作者: addition 時(shí)間: 2025-3-27 10:36
Herbert Schumann,Ingeborg Schumannors, the liver again is the most frequent site of relapse in 40%-50% [4, 18]. Once liver metastases have developed, the prognosis is poor, with an expected median survival of 6-9 months [2, 14], the extent of the tumor being the most important prognostic factor [22]. A great deal of work has been do作者: 溫室 時(shí)間: 2025-3-27 17:04 作者: Allowance 時(shí)間: 2025-3-27 19:11 作者: CLOT 時(shí)間: 2025-3-27 22:04 作者: 光明正大 時(shí)間: 2025-3-28 03:10 作者: Bumptious 時(shí)間: 2025-3-28 09:01
Corn Chips and Simulated Potato Chipsf failure after operation alone will be outlined by site and stage, with implications for adjuvant therapy. Results of series utilizing radiation will be presented with an emphasis on North American studies. The potential for the future will be discussed.作者: absorbed 時(shí)間: 2025-3-28 13:05
Combined Modality Therapy of Gastrointestinal Tract Cancer978-3-642-83293-2Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: BLA 時(shí)間: 2025-3-28 18:33
https://doi.org/10.1007/978-1-4613-1477-6mprove the survival rates of patients with potentially curable rectal carcinoma. However, no clear-cut data have yet been presented in this field of clinical investigation, especially with respect to whether pre- or postoperative radiation should be applied and which kind of fractionation or dosage should be given.作者: Gerontology 時(shí)間: 2025-3-28 20:44
Corn Chips and Simulated Potato Chipsf failure after operation alone will be outlined by site and stage, with implications for adjuvant therapy. Results of series utilizing radiation will be presented with an emphasis on North American studies. The potential for the future will be discussed.作者: 我吃花盤旋 時(shí)間: 2025-3-29 00:48 作者: 痛打 時(shí)間: 2025-3-29 03:24
Preoperative (Neoadjuvant) Chemotherapy in Squamous Cell Cancer of the Esophagusor removal is possible only in some of the patients. There have been many efforts to search for ways of improving the treatment results in esophageal cancer [10]. These include surgical techniques [11, 14] as well as combined treatment modalities [3, 8, 15]. Nevertheless, the results obtained have b作者: 無(wú)價(jià)值 時(shí)間: 2025-3-29 07:30
The Effect of Adjuvant Chemotherapy in Gastric Carcinoma Is Dependent on Tumor Histology: 5- Year Re. Extended surgical procedures over the past 20 years have not profoundly altered the poor outcome of patients with gastric carcinoma [2]. This fact indicates that surgery alone may not be enough to control the disease. In 1978 we began a prospective randomized, one-center trial to determine, whethe作者: Living-Will 時(shí)間: 2025-3-29 14:58 作者: Orchiectomy 時(shí)間: 2025-3-29 19:17 作者: AGGER 時(shí)間: 2025-3-29 22:19
Approach to Primary Liver Cancerlarly in these countries, but also in Europe and other continents, most hepatocellular carcinomas are associated with liver cirrhosis. In contrast to this high frequency, therapeutic experience with hepatocellular or cholangiocellular carcinomas has been very limited, at least in Europe. This is not作者: Presbyopia 時(shí)間: 2025-3-30 03:18
Biliary Duct Cancer: Therapeutic Nihilism or Prospectreflection of increase in incidence or a consequence of better methods for imaging the biliary tree in obstructive jaundice. Benign tumors in the biliary tract do exist, but the overwhelming majority of tumors resulting in obstruction of the bile duct are malignant. In more than 90% of cases these t作者: Inkling 時(shí)間: 2025-3-30 08:05
Treatment of Pancreatic Carcinoma: Therapeutic Nihilism?and the vast majority of patients die within 1 year of diagnosis. Overall survival at 3 years is practically zero [1]. The diagnosis of adenocarcinoma of the pancreas is most often made when the disease is already far advanced. It tends to spread rapidly intra-ab-dominally and can be called the sile作者: 財(cái)主 時(shí)間: 2025-3-30 08:49
Adjuvant Portal Infusion Chemotherapy in Colorectal Cancerors, the liver again is the most frequent site of relapse in 40%-50% [4, 18]. Once liver metastases have developed, the prognosis is poor, with an expected median survival of 6-9 months [2, 14], the extent of the tumor being the most important prognostic factor [22]. A great deal of work has been do作者: ticlopidine 時(shí)間: 2025-3-30 14:57 作者: CEDE 時(shí)間: 2025-3-30 19:19
The Northwest of England Rectal Cancer Trialm of the anal verge. The prognosis following surgery in operable rectal cancer is 30% surviving at 5 years. A large proportion of patients die with evidence of recurrent rectal cancer in the pelvis. Local recurrence appears to be associated with invasion of tumor into surrounding structures which ar作者: 潛伏期 時(shí)間: 2025-3-30 22:22
Five- Year Results of a Prospective and Randomized Study: Experience with Combined Radiotherapy and mprove the survival rates of patients with potentially curable rectal carcinoma. However, no clear-cut data have yet been presented in this field of clinical investigation, especially with respect to whether pre- or postoperative radiation should be applied and which kind of fractionation or dosage 作者: Intractable 時(shí)間: 2025-3-31 01:24
The True Role of External-Beam Irradiation in the Initial Treatment of Cancer of the Rectum which includes 318 cases, is one of the first to demonstrate decisively a significant gain in the 5-year survival rate — 70% vs 60%. For the radiation oncologists the trials are invaluable to show that irradiation is capable of improving the prognosis of cancer of the rectum after surgery. However,作者: Heart-Rate 時(shí)間: 2025-3-31 07:31 作者: 指耕作 時(shí)間: 2025-3-31 09:52
0080-0015 als of Heidelberg and Zurich - must be given the mer- it of achieving these goals. It was especially appropriate for the Department of Surgery in Heidelberg, in978-3-642-83295-6978-3-642-83293-2Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: Anterior 時(shí)間: 2025-3-31 16:28 作者: 樂(lè)器演奏者 時(shí)間: 2025-3-31 20:10 作者: fulcrum 時(shí)間: 2025-3-31 23:30
